AWM
GRCE

Activest Wealth Management’s Grace Therapeutics GRCE Stock Holding History

Activest Wealth Management’s Portfolio GRCE Stock Details GRCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$236 Hold
104
– – ﹤0.01% 1146
2026
Q1 		$482 Hold
104
– – ﹤0.01% 1077
2025
Q4 		$360 Hold
104
– – ﹤0.01% 1016
2025
Q3 		$310 Hold
104
– – ﹤0.01% 996
2025
Q2 		$309 Hold
104
– – ﹤0.01% 928
2025
Q1 		$237 Hold
104
– – ﹤0.01% 926
2024
Q4 		$389 Hold
104
– – ﹤0.01% 561
2024
Q3 		$312 Hold
104
– – ﹤0.01% 502
2024
Q2 		$304 Buy
+104
New +$314 ﹤0.01% 477

Other funds holding GRCE

KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Activest Wealth Management's GRCE Position: Q2 2026 in Review

Activest Wealth Management held its Grace Therapeutics (GRCE) position steady in Q2 2026 at 104 shares worth $236. The position accounts for ﹤0.01% of the portfolio, ranked #1146.

Activest Wealth Management first reported a position in GRCE in Q2 2024 and has held it in 9 quarters since. The position peaked at $482 in Q1 2026. 4 funds tracked by Wall St. Rank hold GRCE as of Q2 2026.

  • Activest Wealth Management held 104 shares of Grace Therapeutics worth $236 as of Q2 2026.
  • Activest Wealth Management left its Grace Therapeutics share count unchanged in Q2 2026.
  • Grace Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #1146 holding.
  • Activest Wealth Management first reported a position in Grace Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Activest Wealth Management's Grace Therapeutics position peaked at $482 in Q1 2026.
  • 4 funds tracked by Wall St. Rank held Grace Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.